Adam Sherwat
Dr. Adam Sherwat is the director of the Office of Infectious Diseases in the FDA’s Center for Drug Evaluation and Research, where he plays a significant role in overseeing the approval of new medications, including the recent approval of novel antibiotics to combat gonorrhea.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 9.00 | 0.04% | +0% | 331,002,651 | 148,033 | $21,000,000 | 9,392$ |
| Totals | 1 | 331,002,651 | 148,033 | $21,000,000 | 9,392$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Dr. Adam Sherwat, director of the Office of Infectious Diseases in the FDA’s Center for Drug Evaluation and Research, commented on the significance of the new treatment options for gonorrhea.
9